Piramal Pharma Limited (PPLPHARMA.NS)
INR 260.5
(-1.59%)
INR 260.5
(-1.59%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 153.11 Billion INR | 5.43% |
| 2022 | 145.22 Billion INR | 101.47% |
| 2021 | 72.08 Billion INR | 25.22% |
| 2020 | 57.56 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 152.41 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 153.11 Billion INR | 5.43% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 153.11 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 147.75 Billion INR | 0.0% |
| 2022 Q2 | 136.7 Billion INR | 0.0% |
| 2022 FY | 145.22 Billion INR | 101.47% |
| 2022 Q4 | 145.22 Billion INR | 3.52% |
| 2022 Q3 | 140.29 Billion INR | 2.62% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 72.08 Billion INR | 0.0% |
| 2021 FY | 72.08 Billion INR | 25.22% |
| 2020 FY | 57.56 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biocon Limited | 560.7 Billion INR | 72.692% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | -1346.083% |
| Concord Biotech Limited | 17 Billion INR | -800.319% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | -59.807% |
| Jubilant Ingrevia Limited | 47.31 Billion INR | -223.588% |
| Lyka Labs Limited | 1.56 Billion INR | -9669.902% |
| Panacea Biotec Limited | 12.4 Billion INR | -1134.147% |
| SMS Lifesciences India Limited | 3.9 Billion INR | -3820.884% |
| Supriya Lifescience Limited | 9.21 Billion INR | -1562.091% |
| Syngene International Limited | 61.51 Billion INR | -148.908% |
| TAKE Solutions Limited | 881.05 Million INR | -17279.048% |
| Zota Health Care Limited | 2.28 Billion INR | -6606.044% |